Skip to main
  1. Stocks
  2. CME Group
  3. Forecast
CME

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 15%
Buy 46%
Hold 31%
Sell 8%
Strong Sell 0%

Bulls say

CME Group is well positioned for durable fundamental growth because its exchange franchise combines dominant liquidity, broad product breadth, and a capital-light model that supports high incremental margins and resilient cash generation. Recent results reinforced that strength, with record revenue of $1.74 billion, adjusted EPS of $3.02, ADV up 16% year over year, and open interest at 128 million contracts, while market data fees and clearing fees continued to support earnings quality. Its long-term outlook is further strengthened by pricing power in interest rates, expansion into cash foreign exchange and fixed income through NEX, a 27% stake in S&P Dow Jones Indices, and new products such as compute futures and 24/7 trading that can broaden participation and sustain volume growth.

Bears say

CME Group is exposed to slowing Average Daily Volume and weaker Revenue per Contract trends, which could pressure core revenue even as it benefits from a broad product mix across rates, equities, FX, energy, metals, and commodities. Its 27% stake in S&P Dow Jones Indices and exclusive venue status for S&P futures are meaningful, but the outlook remains challenged by market share erosion, especially as FMX, CBOE, and ICE compete in interest rates, equity volatility, and energy. The 2007, 2008, and 2018 acquisitions also add execution risk, while shifts in short-term rate expectations, yield curve slope, credit spreads, and regulation could further weigh on volumes and pricing.

CME Group (CME) has been analyzed by 13 analysts, with a consensus rating of Buy. 15% of analysts recommend a Strong Buy, 46% recommend Buy, 31% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

CME Group (CME) Analyst Forecast & Price Prediction

Get the latest CME Group (CME) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CME Group (CME)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Buy based on their latest research and market trends.

According to 13 analysts, CME Group (CME) has a Buy consensus rating as of Nov 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $313.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $313.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


CME Group (CME) Analyst Forecast & Price Prediction

Get the latest CME Group (CME) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CME Group (CME)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CME stock data and trends